Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-11

Clinical Trial Update: Oral Melatonin Versus Oral Tranexamic Acid in the Management of Melasma [Phase 2]

View source ↗

Summary

The document describes a Phase 2 clinical trial comparing oral melatonin with oral tranexamic acid for the management of facial melasma, currently enrolling by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)
  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Hina Malik | Conditions: Melasma (Facial Melasma) | Phase 2 | Status: ENROLLING_BY_INVITATION